Related references
Note: Only part of the references are listed.Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development
Tatsuki Fukami et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
DNA methylation determines the regulation of pregnane X receptor on CYP3A4 expression
Xiaofei Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2021)
m6A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2
Seiya Takemoto et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of AADAC Genetic Polymorphisms on Hydrolase Activity
Keiya Hirosawa et al.
DRUG METABOLISM AND DISPOSITION (2021)
Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans
Yoshiyuki Sakai et al.
LIFE SCIENCES (2021)
RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms
Kaori Nozaki et al.
DRUG METABOLISM AND DISPOSITION (2019)
CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation
Hang Zeng et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation
Ina Katrine Nitschke Pettersen et al.
MITOCHONDRION (2019)
Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance
Maxwell A. Ruby et al.
CELL REPORTS (2017)
The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
Sander Kersten et al.
BIOCHIMIE (2017)
Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity
Tatsuki Fukami et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases
Tatsuki Fukami et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Transcriptome Analysis of K-877 (a Novel Selective PPAR alpha Modulator (SPPARM alpha))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver
Sana Raza-Iqbal et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia
Yuki Kobayashi et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Transcription Factor-Mediated Regulation of Carboxylesterase Enzymes in Livers of Mice
Youcai Zhang et al.
DRUG METABOLISM AND DISPOSITION (2012)
Species Differences in Tissue Distribution and Enzyme Activities of Arylacetamide Deacetylase in Human, Rat, and Mouse
Yuki Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: Rifampicin, rifabutin, and rifapentine
Akinori Nakajima et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms
Daisuke Yamasaki et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
PPARα Is Regulated by miR-21 and miR-27b in Human Liver
Katsuhiko Kida et al.
PHARMACEUTICAL RESEARCH (2011)
Gene expression profile of Li23, a new human hepatoma cell line that enables robust hepatitis C virus replication: Comparison with HuH-7 and other hepatic cell lines
Kyoko Mori et al.
HEPATOLOGY RESEARCH (2010)
Peroxisome proliferator activated receptor α (PPARα) and PPAR gamma coactivator (PGC-1α) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements
Shulan Song et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes
Jian Yang et al.
TOXICOLOGY LETTERS (2010)
Human Arylacetamide Deacetylase Is a Principal Enzyme in Flutamide Hydrolysis
Akinobu Watanabe et al.
DRUG METABOLISM AND DISPOSITION (2009)
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
Matteo Ricchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Glucocorticoid hormone regulates the circadian coordination of μ-opioid receptor expression in mouse Brainstem
M Yoshida et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Peroxisome proliferator-activated receptor (PPAR)-α:: A pharmacological target with a promising future
DH van Raalte et al.
PHARMACEUTICAL RESEARCH (2004)
Human CYP1B1 is regulated by estradiol via estrogen receptor
Y Tsuchiya et al.
CANCER RESEARCH (2004)
Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks
B Selmaoui et al.
LIFE SCIENCES (2003)
Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes
L Richert et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2003)
Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR
M Nishimura et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2002)
Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation
JI Trickett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
